Vivos Therapeutics, Inc. (VVOS): Gross Profit
$10.54M
Year ended 2025-12-31
$12.94M
Trailing 12 months to 2026-06-30
+1.7%
3-year compound annual growth
+0.2%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.54M | +16.9% | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | $9.02M | +9.0% | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | $8.27M | -17.4% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $10.02M | -20.5% | 2024-07-30, From 2022-01-01 |
| 2021-12-31 | $12.60M | +21.0% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $10.41M | +20.3% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $8.66M | n/a | 2021-03-25, From 2019-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $10.54M | +16.9% |
| Nephros Inc (NEPH) | 2025-12-31 | $11.62M | +33.3% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $11.39M | +61.9% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $12.95M | +22.6% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $7.42M | +35.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $8.93M | -32.8% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $9.57M | -55.5% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $12.66M | -4.5% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $18.88M | -42.2% |
Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗